<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2d1 20170631//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article" dtd-version="1.2d1" specific-use="production" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">BIORXIV</journal-id>
<journal-title-group>
<journal-title>bioRxiv</journal-title>
<abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title>
</journal-title-group>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1101/370924</article-id>
<article-version>1.1</article-version>
<article-categories>
<subj-group subj-group-type="author-type">
<subject>Regular Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>New Results</subject>
</subj-group>
<subj-group subj-group-type="hwp-journal-coll">
<subject>Neuroscience</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Neuronal overexpression of <italic>DYRK1A/minibrain</italic> alters motor decline, neurodegeneration and synaptic plasticity in <italic>Drosophila</italic></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lowe</surname>
<given-names>Simon A</given-names>
</name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Usowicz</surname>
<given-names>Maria M</given-names>
</name>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4741-2363</contrib-id>
<name>
<surname>Hodge</surname>
<given-names>James JL</given-names>
</name>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
<aff id="a1"><institution>School of Physiology, Pharmacology and Neuroscience, University of Bristol, University Walk</institution>, Bristol BS8 1TD, <country>UK</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>corresponding authors: Maria Usowicz (<email>m.m.usowicz@bristol.ac.uk</email>) and James Hodge (<email>james.hodge@bristol.ac.uk</email>)</corresp>
</author-notes>
<pub-date pub-type="epub">
<year>2018</year>
</pub-date>
<elocation-id>370924</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>7</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>17</day>
<month>7</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>7</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2018, Posted by Cold Spring Harbor Laboratory</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link></license-p></license>
</permissions>
<self-uri xlink:href="370924.pdf" content-type="pdf" xlink:role="full-text"/>
<abstract>
<title>Abstract</title>
<p>Down syndrome (DS) is characterised by abnormal cognitive and motor development, and later in life by progressive Alzheimer&#x2019;s disease (AD)-like dementia, neuropathology, declining motor function and shorter life expectancy. It is caused by trisomy of chromosome 21 (Hsa21), but how individual Hsa21 genes contribute to various aspects of the disorder is incompletely understood. Previous work has demonstrated a role for triplication of the Hsa21 gene <italic>DYRK1A</italic> in cognitive and motor deficits, as well as in altered neurogenesis and neurofibrillary degeneration in the DS brain, but its contribution to other DS phenotypes is unclear. Here we demonstrate that overexpression of <italic>minibrain</italic> (<italic>mnb</italic>), the <italic>Drosophila</italic> ortholog of <italic>DYRK1A</italic>, in the <italic>Drosophila</italic> nervous system accelerated age-dependent decline in motor performance and shortened lifespan. Overexpression of <italic>mnb</italic> in the eye was neurotoxic and overexpression in ellipsoid body neurons in the brain caused age-dependent neurodegeneration. At the larval neuromuscular junction, an established model for mammalian central glutamatergic synapses, neuronal <italic>mnb</italic> overexpression enhanced spontaneous vesicular transmitter release. It also slowed recovery from short-term depression of evoked transmitter release induced by high-frequency nerve stimulation and increased the number of boutons in one of the two glutamatergic motor neurons innervating the muscle. These results provide further insight into the roles of <italic>DYRK1A</italic> triplication in abnormal aging and synaptic dysfunction in DS.</p>
<sec>
<title>Author summary</title>
<p>Down syndrome (DS) is caused by three copies of chromosome 21 instead of the usual two. It is characterised by cognitive and motor deficits, which worsen with age resulting in Alzheimer&#x2019;s disease (AD). Which genes on chromosome 21 cause these phenotypes is incompletely understood. Here we demonstrate that neuronal overexpression of <italic>minibrain</italic>, the <italic>Drosophila</italic> ortholog of the chromosome 21 gene <italic>DYRK1A</italic>, causes age-dependent degeneration of brain neurons, accelerates age-dependent decline in motor performance and shortens lifespan. It also modifies presynaptic structure, enhances spontaneous transmitter release and slows recovery from short-term depression of synaptic transmission at a model glutamatergic synapse. These findings give insight into the role of <italic>DYRK1A</italic> overexpression in aberrant aging and altered information processing in DS and AD.</p>
</sec>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords</title>
<kwd>Down&#x2019;s syndrome</kwd>
<kwd>Alzheimer&#x2019;s disease</kwd>
<kwd>DYRK1A/minibrain</kwd>
<kwd><italic>Drosophila</italic></kwd>
<kwd>neuromuscular junction</kwd>
<kwd>synaptic transmission</kwd>
<kwd>neurodegeneration</kwd>
<kwd>motor decline</kwd>
</kwd-group>
<counts>
<page-count count="29"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Down syndrome (DS, also known as Down&#x2019;s syndrome) or trisomy 21 is caused by the presence of three copies of chromosome 21 (Hsa21) instead of the usual two [<xref ref-type="bibr" rid="c1">1</xref>]. It is characterised by cognitive impairment [<xref ref-type="bibr" rid="c2">2</xref>] and the delayed and incomplete acquisition of motor skills [<xref ref-type="bibr" rid="c3">3</xref>] as a result of abnormal development of the nervous system [<xref ref-type="bibr" rid="c4">4</xref>]. Individuals with DS almost invariably develop Alzheimer&#x2019;s disease (AD)-like symptoms (AD-DS). These include progressive dementia after 40 years of age, the onset of amyloid plaques, neurofibrillary tangles and neurodegeneration after 10 &#x2013; 20 years [<xref ref-type="bibr" rid="c5">5</xref>, <xref ref-type="bibr" rid="c6">6</xref>], faster age-dependent motor decline that is an early marker for the onset of cognitive decline and health deterioration [<xref ref-type="bibr" rid="c7">7</xref>, <xref ref-type="bibr" rid="c8">8</xref>], and a shorter mean life expectancy by approximately 28 years [<xref ref-type="bibr" rid="c9">9</xref>]. Currently there is no treatment for DS or AD; our understanding of the mechanisms of the disorder is incomplete and this hampers the development of effective therapies.</p>
<p>One of the Hsa21 genes, <italic>DYRK1A</italic> (dual specificity tyrosine-phosphorylation-regulated kinase 1A), is a candidate causative gene for the structural and functional changes that occur in the DS brain, and for the associated cognitive and motor deficits [<xref ref-type="bibr" rid="c1">1</xref>, <xref ref-type="bibr" rid="c4">4</xref>]. DYRK1A/Dyrk1a mRNA and protein are expressed throughout the brain in humans and rodents, wherein DYRK1A controls aspects of neuronal development and function [<xref ref-type="bibr" rid="c10">10</xref>-<xref ref-type="bibr" rid="c12">12</xref>]. DYRK1A/Dyrk1a mRNA and protein expression is increased in DS brain and in the brain of different mouse models of DS [<xref ref-type="bibr" rid="c10">10</xref>-<xref ref-type="bibr" rid="c13">13</xref>], whether the gene is triplicated as part of a genomic segment, as in Dp1Yey, Ts65Dn, Ts1Cje and Tc1 mice, or alone as in TgDyrk1a and TgDYRK1A mice [<xref ref-type="bibr" rid="c1">1</xref>].</p>
<p>DS-associated cognitive and motor deficits are replicated by overexpression of <italic>Dyr1ka</italic> in mice [<xref ref-type="bibr" rid="c13">13</xref>-<xref ref-type="bibr" rid="c22">22</xref>]. However, the contribution of <italic>DYRK1A</italic> overexpression to the faster age-dependent decline in cognitive and motor function in DS is unclear. It is predicted to play a role as Dyrk1a overexpression intensifies with age in the brain of Ts65Dn and Ts1Cje mouse models of DS [<xref ref-type="bibr" rid="c12">12</xref>, <xref ref-type="bibr" rid="c15">15</xref>, <xref ref-type="bibr" rid="c23">23</xref>, <xref ref-type="bibr" rid="c24">24</xref>], it is associated with AD-DS-like histopathological changes in the brain of aged Ts65Dn mice [<xref ref-type="bibr" rid="c5">5</xref>, <xref ref-type="bibr" rid="c25">25</xref>] and it enhances APP processing and the formation of hyperphosphorylated Tau aggregates in rat hippocampal progenitor cells <italic>in vitro</italic> [<xref ref-type="bibr" rid="c26">26</xref>]. The contribution of <italic>DYRK1A</italic> overexpression to the shorter life expectancy in DS has also not been explored.</p>
<p>Cognitive and motor dysfunction in individuals with DS and in mouse models of DS are associated with changes in synaptic plasticity and with changes in the number and structure of GABAergic and glutamatergic brain neurons and synapses [<xref ref-type="bibr" rid="c10">10</xref>, <xref ref-type="bibr" rid="c27">27</xref>, <xref ref-type="bibr" rid="c28">28</xref>]. Such modifications have been linked to <italic>Dyrk1a</italic> overexpression [<xref ref-type="bibr" rid="c10">10</xref>, <xref ref-type="bibr" rid="c13">13</xref>, <xref ref-type="bibr" rid="c25">25</xref>, <xref ref-type="bibr" rid="c29">29</xref>], but the effects of <italic>Dyrk1a</italic> overexpression on the basic properties of synaptic function have rarely been explored. In one study, there was no change in the frequency of miniature excitatory synaptic currents (mEPSCs) or the probability of electrically-evoked glutamate release in the prefrontal cortex of TgDyrk1a mice [<xref ref-type="bibr" rid="c30">30</xref>]. Nevertheless, since Dyrk1a controls the activity of proteins that regulate endocytosis [<xref ref-type="bibr" rid="c31">31</xref>] and <italic>DYRK1A</italic> overexpression slows endocytosis of transmitter vesicles in hippocampal presynaptic membranes from TgDYRK1A mice [<xref ref-type="bibr" rid="c32">32</xref>], modulation of transmitter release at other glutamatergic synapses is likely.</p>
<p>To investigate the contribution of <italic>DYRK1A</italic> overexpression in the nervous system to various aspects of DS, we overexpressed <italic>minibrain</italic> (<italic>mnb</italic>), the <italic>Drosophila</italic> ortholog of <italic>DYRK1A</italic> [<xref ref-type="bibr" rid="c10">10</xref>], in the <italic>Drosophila</italic> nervous system and implemented well-established assays in larvae and adult flies [<xref ref-type="bibr" rid="c33">33</xref>-<xref ref-type="bibr" rid="c35">35</xref>]. The assays monitored motor impairment and its development with age, lifespan, age-related neurodegeneration, and synaptic dysfunction. Due to their short lifecycle, <italic>Drosophila</italic> are one of the pre-eminent models for aging and neurodegeneration [<xref ref-type="bibr" rid="c36">36</xref>], both aspects of DS that are more difficult to investigate in mice. The <italic>Drosophila</italic> larval neuromuscular junction (NMJ) is a well-established model for mammalian central glutamatergic synapses and is easily accessible to electrophysiology [<xref ref-type="bibr" rid="c33">33</xref>]. <italic>Mnb</italic> is expressed presynaptically at larval NMJs and reducing its expression changes motor nerve terminal structure and impairs recycling of transmitter vesicles [<xref ref-type="bibr" rid="c37">37</xref>]. Overexpression of the <italic>mnb-F</italic> transcript induces a different change in nerve terminal morphology without apparently affecting basal synaptic transmission [<xref ref-type="bibr" rid="c37">37</xref>]. Here we report the effects of neuronal overexpression of <italic>mnb-H</italic>, which encodes the longest mnb splice variant [<xref ref-type="bibr" rid="c38">38</xref>], on motor function, the rate of motor decline with age, lifespan, age-related neurodegeneration, presynaptic structure, spontaneous transmitter release and recovery from frequency-dependent depression of electrically-evoked transmitter release.</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>Neuronal overexpression of <italic>mnb</italic> produced motor deficits in larvae, accelerated age-dependent motor decline in adult flies and shortened adult lifespan</title>
<p>The effect of <italic>mnb</italic> overexpression in the nervous system on motor function (specifically the <italic>mnb-H</italic> splice variant) was tested using two assays of fly larval locomotion. <italic>Elav&#x003E;mnb</italic> larvae, overexpressing <italic>mnb</italic> throughout the nervous system under the control of the <italic>Elav-Gal4</italic> driver [<xref ref-type="bibr" rid="c39">39</xref>], did not move as far as control larvae (<italic>Elav/&#x002B;</italic>) in a free movement assay (<xref ref-type="fig" rid="fig1">Fig. 1A</xref>), which measures the ability of larvae to perform rhythmic muscle contractions necessary for gross locomotion [<xref ref-type="bibr" rid="c40">40</xref>]. They also took longer to complete a self-righting assay (<xref ref-type="fig" rid="fig1">Fig. 1B</xref>), which is a more complex motor task requiring larvae to enact a co-ordinated sequence of movements to right themselves after being rolled onto their backs [<xref ref-type="bibr" rid="c41">41</xref>]. To assess the impact of neuronal <italic>mnb</italic> overexpression on age-related decline in locomotor function, the performance of the same cohorts of adult flies was assessed in a negative geotaxis assay at different ages [<xref ref-type="bibr" rid="c36">36</xref>]. This showed acceleration in <italic>Elav&#x003E;mnb</italic> flies of the usual age-related decline in performance (<italic>Elav/&#x002B;</italic>). There was also evident shortening of the lifespan of <italic>Elav</italic>&#x003E;<italic>mnb</italic> flies, so that the median lifespan was reduced by almost 50&#x0025; (<italic>Elav/&#x002B;</italic>, 73 days; <italic>Elav&#x003E;mnb</italic>, 38 days; <xref ref-type="fig" rid="fig1">Fig. 1D</xref>). These results indicate that neuronal overexpression of <italic>mnb</italic> alone produced a motor deficit and abnormal aging characterised by accelerated age-related locomotor impairment and a shorter lifespan.</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1.</label>
<caption>
<title>Motor deficits in larvae, accelerated age-dependent motor decline in adult flies and shortened adult lifespan due to neuronal overexpression of <italic>mnb</italic></title>
<p>(A) <italic>Elav&#x003E;mnb</italic> larvae crossed fewer lines of a 0.5 cm grid in 60 s than control larvae (<italic>Elav/&#x002B;</italic>, 14.7 &#x00B1; 0.44, <italic>n</italic> &#x003D; 15; <italic>Elav&#x003E;mnb</italic>, 12.1 &#x00B1; 0.86, <italic>n</italic> &#x003D; 15; mean &#x00B1; SEM, &#x002A;<italic>P</italic> &#x003D; 0.014, Student&#x2019;s <italic>t</italic>-test). (B) <italic>Elav&#x003E;mnb</italic> larvae took longer than controls to perform a self-righting task (<italic>Elav/&#x002B;</italic>, 5.5 &#x00B1; 1.16 s, <italic>n</italic> &#x003D; 15; <italic>Elav&#x003E;mnb</italic>, 12 &#x00B1; 2.56 s; <italic>n</italic> &#x003D; 15; mean &#x00B1; SEM, &#x002A;<italic>P</italic> &#x003D; 0.029, Student&#x2019;s <italic>t</italic>-test). Each point in the plots (A, B) is from a different animal; horizontal lines indicate mean values. (C) The age-dependent decline in climbing ability in a negative geotaxis assay was steeper for <italic>Elav&#x003E;mnb</italic> adult flies than for controls (<italic>F</italic> (3,84) &#x003D; 13.8; &#x002A;&#x002A;&#x002A;<italic>P</italic>&#x003C; 0.0001, repeated measures two-way ANOVA, <italic>n</italic> &#x003D; 15 groups of flies); at 1 day old there was no difference in the percentage of flies that climbed successfully (<italic>Elav/&#x002B;</italic>, 90.59 &#x00B1; 1.82 &#x0025;, <italic>n</italic> &#x003D; 15; <italic>Elav&#x003E;mnb</italic> &#x00B1; 85.94 &#x00B1; 1.46 &#x0025;, <italic>n</italic> &#x003D; 15; mean &#x00B1; SEM, <italic>P</italic> &#x003D; 0.8262, repeated measures two-way ANOVA and Sidak&#x2019;s multiple comparison). Values plotted are mean &#x00B1; SEM, <italic>n</italic> &#x003D; 15 groups of 10 flies for each genotype. (D) <italic>Elav&#x003E;mnb</italic> flies had a shorter lifespan relative to controls (<italic>n</italic> &#x003D; 100 animals per genotype at day 0, &#x002A;&#x002A;&#x002A;<italic>P</italic>&#x003C; 0.0001, log-rank (Mantel-Cox) test).</p>
</caption>
<graphic xlink:href="370924_fig1.tif"/>
</fig>
</sec>
<sec id="s2b">
<title>Overexpression of <italic>mnb</italic> caused neurodegeneration in adult flies</title>
<p>As <italic>DYRK1A</italic> triplication has been linked to degeneration of brain neurons in AD-DS and in Ts65Dn mice [<xref ref-type="bibr" rid="c25">25</xref>, <xref ref-type="bibr" rid="c42">42</xref>], we tested the possibility that neuronal overexpression of <italic>mnb</italic> is sufficient to cause neurotoxicity and age-related neurodegeneration using two established assays of neurodegeneration in adult flies [<xref ref-type="bibr" rid="c34">34</xref>, <xref ref-type="bibr" rid="c35">35</xref>]. In the first, <italic>mnb</italic> was overexpressed in the eye through development and adulthood using the <italic>Glass multimer reporter</italic> driver (<italic>GMR-Gal4</italic>) [<xref ref-type="bibr" rid="c43">43</xref>]. The <italic>GMR&#x003E;mnb</italic> flies, but not control flies (<italic>GMR/&#x002B;</italic>), had a reduced eye surface area and a visible &#x201C;rough eye&#x201D; phenotype (<xref ref-type="fig" rid="fig2">Fig. 2A</xref>), both of which indicate neural death and the resultant breakdown of the regularly spaced array of ommatidia making up the retina. In a second assay, the <italic>EB1</italic> driver (<italic>EB1-Gal4</italic>) was used to overexpress <italic>mnb</italic> in the ellipsoid body (EB), a subpopulation of neurons within the central complex of the brain implicated in locomotor control (<xref ref-type="fig" rid="fig2">Fig. 2B</xref>) [<xref ref-type="bibr" rid="c44">44</xref>]. The EB cells also expressed membrane-bound GFP which enabled their visualisation. At 1 day old, there was no difference in the number of GFP-positive EB neurons between control (<italic>EB1/&#x002B;</italic>) and <italic>EB1&#x003E;mnb</italic> flies, whereas at day 40 the number of EB neurons was significantly reduced in <italic>EB1&#x003E;mnb</italic> flies but not in control flies, and the remaining cells were fragmented and misshapen (<xref ref-type="fig" rid="fig2">Fig. 2C</xref>). Therefore, neurotoxicity caused by <italic>mnb</italic> overexpression promoted age-related neurodegeneration in a central neuron population.</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2.</label>
<caption>
<title>Neurotoxicity and age-related neurodegeneration caused by <italic>mnb</italic> overexpression</title>
<p>(A) (<italic>Left</italic>) Representative images of the eyes of control adult flies (<italic>GMR/&#x002B;</italic>) and flies with <italic>mnb</italic> overexpression driven in the eye by <italic>GMR-Gal4</italic> (<italic>GMR&#x003E;mnb</italic>). (<italic>Right</italic>) The surface area of the eyes in <italic>GMR&#x003E;mnb</italic> flies was reduced (<italic>GMR/&#x002B;</italic>, 0.14 &#x00B1; 0.005 mm<sup>2</sup>, <italic>n</italic> &#x003D; 10; <italic>GMR&#x003E;mnb</italic>, 0.09 &#x00B1; 0.005 mm<sup>2</sup>, <italic>n</italic> &#x003D; 10; mean &#x00B1; SEM, &#x002A;&#x002A;&#x002A;<italic>P</italic> &#x003C; 0.0001, Student&#x2019;s <italic>t</italic>-test). Each point in the plot is from a different animal, horizontal lines indicate means. (B) (<italic>Left</italic>) Representative images of clusters of GFP-expressing ellipsoid body neurons in one brain hemisphere, with and without <italic>mnb</italic> overexpression driven by <italic>EB1-Gal4</italic>, in 1 d and 40 d old flies. Calibration bar is 10 &#x03BC;m. (<italic>Right</italic>) The number of intact cells did not differ at 1 d (<italic>EB1&#x003E;mCD8-GFP</italic>; 32.59 &#x00B1; 0.48, <italic>n</italic> &#x003D; 15 (black); <italic>EB1&#x003E;mCD8-GFP, mnb</italic>; 31.47 &#x00B1; 0.47, <italic>n</italic> &#x003D; 15 (grey); mean &#x00B1; SEM, <italic>P</italic> &#x003D; 0.757, repeated measures two-way ANOVA and Sidak&#x2019;s multiple comparison) but decreased between 1 and 40 d in <italic>EB1&#x003E;mCD8-GFP, mnb</italic> flies; (<italic>F</italic> (1,28) &#x003D; 10.56; <italic>n</italic> &#x003D; 15; <italic>P</italic> &#x003D; 0.003, repeated measures two-way ANOVA). Values plotted are mean &#x00B1; SEM from 15 flies for each genotype.</p>
</caption>
<graphic xlink:href="370924_fig2.tif"/>
</fig>
</sec>
<sec id="s2c">
<title>Overexpression of <italic>mnb</italic> in motor neurons increased the number of synaptic boutons at the larval NMJ</title>
<p>To investigate the effect of <italic>mnb</italic> overexpression on presynaptic morphology, <italic>mnb</italic> was overexpressed in glutamatergic motor neurons of <italic>Drosophila</italic> larvae using <italic>OK371-Gal4</italic> [<xref ref-type="bibr" rid="c45">45</xref>]. The neuronal membranes were labelled with horseradish peroxidase (HRP) and boutons of the two motor neurons innervating larval muscles 6 and 7 were differentiated according to stronger postsynaptic expression of Discs large (Dlg) opposite 1b (big) boutons than 1s (small) boutons [<xref ref-type="bibr" rid="c46">46</xref>]. Analysis of the NMJ in the second abdominal larval segment, A2, showed that <italic>mnb</italic> overexpression affected the morphology of the nerve terminals of only one of the motor neurons; it increased the number of 1b boutons but did not alter the number of 1s boutons (<xref ref-type="fig" rid="fig3">Fig. 3A-B</xref>). The effect was not secondary to changes in muscle size, as this did not differ (surface area of muscle 6: <italic>OK371/&#x002B;</italic>, 44752 &#x00B1; 1407 &#x03BC;m<sup>2</sup>, <italic>n</italic> &#x003D; 15; <italic>OK371&#x003E;mnb</italic>, 44681 &#x00B1; 3684 &#x03BC;m<sup>2</sup>, <italic>n</italic> &#x003D; 15, <italic>P</italic> &#x003D; 0.9857).</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3.</label>
<caption>
<title>Overexpression of <italic>mnb</italic> in motor neurons increased the number of 1b boutons</title>
<p>(A) Representative images of motor nerve endings at the NMJ of muscle 6/7 in the A2 segment of <italic>OK371/&#x002B;</italic> (<italic>top</italic>) and <italic>OK371&#x003E;mnb</italic> (<italic>bottom</italic>) larvae. The neuronal membrane is labelled with HRP (green); type 1b boutons but not type 1s boutons (arrowheads) are preferentially labelled with Dlg (magenta). Scale bar is 25 &#x03BC;m. (B) <italic>OK371&#x003E;mnb</italic> NMJs had more 1b boutons (<italic>OK371/&#x002B;</italic>, 24.93 &#x00B1; 1.11, <italic>n</italic> &#x003D; 15; <italic>OK371&#x003E;mnb</italic>, 32.80 &#x00B1; 1.52, <italic>n</italic> &#x003D; 15, mean &#x00B1; SEM, &#x002A;&#x002A;&#x002A;<italic>P</italic> &#x003D; 0.0003, Student&#x2019;s <italic>t</italic>-test) but there was no difference in the number of 1s boutons (<italic>OK371/&#x002B;</italic>, 32.6 &#x00B1; 2.62, <italic>n</italic> &#x003D; 15; <italic>OK371&#x003E;mnb</italic>, 38.6 &#x00B1; 3.34, <italic>n</italic> &#x003D;15, mean &#x00B1; SEM, <italic>P</italic> &#x003D; 0.169, Student&#x2019;s <italic>t</italic>-test). Each value plotted is from a different animal, horizontal lines indicate means.</p>
</caption>
<graphic xlink:href="370924_fig3.tif"/>
</fig>
</sec>
<sec id="s2d">
<title>Overexpression of <italic>mnb</italic> in motor neurons altered basal synaptic transmission at the larval NMJ</title>
<p>As neuronal overexpression of <italic>mnb</italic> increased the number of 1b boutons at the larval NMJ, and because previous studies have implicated Dyrk1a/mnb in the control of the recycling of neurotransmitter vesicles [<xref ref-type="bibr" rid="c31">31</xref>, <xref ref-type="bibr" rid="c32">32</xref>, <xref ref-type="bibr" rid="c37">37</xref>], we investigated if spontaneous glutamate release was altered by recording spontaneously occurring miniature excitatory junction potentials (mEJPs) with intracellular microelectrodes. Since the muscle 6/7 NMJ is innervated by 1b and 1s boutons, mEJPs usually result from the release of neurotransmitter vesicles from both types of boutons [<xref ref-type="bibr" rid="c47">47</xref>]. Our recordings revealed that mEJPs occurred more frequently but were smaller in <italic>OK371&#x003E;mnb</italic> larvae (<xref ref-type="fig" rid="fig4">Fig. 4A-B</xref>). The decrease in amplitude was not secondary to a change in the electrical properties of the muscle as there was no difference in input resistance (<italic>OK371/&#x002B;</italic>, 3.37 &#x00B1; 0.69 M&#x03A9;, <italic>n</italic> &#x003D; 8; <italic>OK371&#x003E;mnb</italic> &#x003D; 3.99 &#x00B1; 0.99 M&#x03A9;, <italic>n</italic> &#x003D; 8, <italic>P</italic> &#x003D; 0.613) or resting potential (<italic>OK371/&#x002B;</italic>, &#x2212;69.6 &#x00B1; 1.48 mV, <italic>n</italic> &#x003D; 8; <italic>OK371&#x003E;mnb</italic>, &#x2212; 67.6 &#x00B1; 1.55 mV, <italic>n</italic> &#x003D; 8, <italic>P</italic> &#x003D; 0.365). Although we did not directly investigate the source of the more frequent smaller mEJPs, the notion that they are due to the observed selective increase in the number of 1b boutons is suggested by the fact that 1b-dependent mEJPs are smaller than 1s-dependent mEJPS [<xref ref-type="bibr" rid="c47">47</xref>]. In parallel with the changes in spontaneous synaptic events, there was a small (&#x007E;11 &#x0025;) decrease in the mean amplitude of electrically-evoked excitatory junction potentials (EJPs) caused by single stimuli applied to the nerve at a low frequency (0.1 Hz) (<xref ref-type="fig" rid="fig4">Fig. 4C</xref>). There was no difference between EJPs in mean rise time (<italic>OK371/&#x002B;</italic>, 2.67 &#x00B1; 0.178 ms, <italic>n</italic> &#x003D; 8; <italic>OK371&#x003E;mnb</italic>, 3.23 &#x00B1; 0.33 ms, <italic>n</italic> &#x003D; 8, <italic>P</italic> &#x003D; 0.728) or mean time constant of decay (<italic>OK371/&#x002B;</italic>, 44.9 &#x00B1; 3.1 ms, <italic>n</italic> &#x003D; 8; <italic>OK371&#x003E;mnb</italic>, 36.6 &#x00B1; 4.6 ms, <italic>n</italic> &#x003D; 8, <italic>P</italic> &#x003D; 0.154). The relatively small fall in EJP amplitude is likely to reflect the smaller size of the 1b-dependent component of the EJP relative to that of the 1s-dependent component [<xref ref-type="bibr" rid="c47">47</xref>].</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4.</label>
<caption>
<title>Overexpression of <italic>mnb</italic> in motor neurons altered basal synaptic transmission.</title>
<p>(A) Representative voltage recordings (3 s traces) from NMJs of <italic>OK371/&#x002B;</italic> (black) and <italic>OK371&#x003E;mnb</italic> (grey) larvae showing spontaneous mEJPs recorded at a membrane potential of &#x2212;70 mV. (B) Cumulative frequency distributions of mEJP amplitude (<italic>left</italic>) and inter-mEJP interval (<italic>right</italic>) (1600 events, 200 from each of 8 NMJ recordings). <italic>OK371&#x003E;mnb</italic> mEJPs were smaller (&#x002A;&#x002A;&#x002A;<italic>P</italic> &#x003C; 0.0001) and more frequent (&#x002A;&#x002A;&#x002A;<italic>P</italic> &#x003C; 0.0001), Kolmogorov-Smirnov test. (C) (<italic>Left</italic>) Representative image of a single electrically-evoked EJP at an <italic>OK371/&#x002B;</italic> NMJ and an <italic>OK371&#x003E;mnb</italic> NMJ at a membrane potential of &#x2212;70 mV. (<italic>Right</italic>) The median EJP amplitude (horizontal line) was reduced in <italic>OK371&#x003E;mnb</italic> NMJs (<italic>OK371/&#x002B;</italic>, 51.26 mV, <italic>n</italic> &#x003D; 8; <italic>OK371&#x003E;mnb</italic>, 45.55 mV, <italic>n</italic> &#x003D; 8; mean &#x00B1; SEM, &#x002A;<italic>P</italic> &#x003D; 0.0281). Each point plotted is from a different animal.</p>
</caption>
<graphic xlink:href="370924_fig4.tif"/>
</fig>
</sec>
<sec id="s2e">
<title>Overexpression of <italic>mnb</italic> in motor neurons slowed recovery from frequency-dependent depression at the larval NMJ</title>
<p>To investigate the effects of neuronal <italic>mnb</italic> overexpression on recycling of synaptic vesicles during electrically-evoked transmitter release, EJPs were evoked with pairs of electrical stimuli separated by intervals of varying duration (10 ms &#x2013; 10 s) or with repeated trains of 10 stimuli applied at a high frequency (10 Hz, a frequency 100 times higher than that at which the single EJPs were evoked) [<xref ref-type="bibr" rid="c48">48</xref>]. At control NMJs, paired pulses separated by intervals shorter than 200 ms caused depression of the amplitude of the second EJP relative to that of the first and the depression was stronger for shorter inter-stimulus intervals (<xref ref-type="fig" rid="fig5">Fig. 5A</xref>). The dependence of paired-pulse depression on interval duration was unaltered in <italic>OK371&#x003E;mnb</italic> larvae (<xref ref-type="fig" rid="fig5">Fig. 5A</xref>), indicating that <italic>mnb</italic> overexpression did not alter release from a readily releasable pool of vesicles [<xref ref-type="bibr" rid="c49">49</xref>]. When transmitter release was evoked at control NMJs with a train of 10 stimuli at 10 Hz, there was rapid depression of the EJP amplitude by &#x007E;20&#x0025; within the first 3 events (<xref ref-type="fig" rid="fig5">Fig. 5B</xref>). In the one-minute interval before the next train, the EJP amplitude recovered fully so that the amplitude of the first EJP in the second train was the same as in the first train (<xref ref-type="fig" rid="fig5">Fig. 5B</xref>). This ability to recover did not wane during the recording; the amplitude of the first EJP in each train did not differ between 8 trains (<xref ref-type="fig" rid="fig5">Fig. 5B</xref>). These effects are consistent with previous studies [<xref ref-type="bibr" rid="c48">48</xref>] and confirm rapid depletion and replenishment of the readily releasable pool of vesicles [<xref ref-type="bibr" rid="c49">49</xref>]. However, the same pattern of nerve stimulation produced different effects at <italic>OK371&#x003E;mnb</italic> NMJs (<xref ref-type="fig" rid="fig5">Fig. 5B</xref>). The percentage decrease in EJP amplitude during each train was the same as at control NMJs, but the depression was not fully reversed during the intervals between trains, so that the first EJP in each train was smaller than the first EJP in the preceding train. The depression in amplitude accumulated over the 8 trains, resulting in an overall fall of 10&#x0025;. To confirm that the changes in EJP amplitude were due to presynaptic changes in transmitter release and were not postsynaptically mediated by a decrease in the unitary depolarisations comprising each EJP, we measured the amplitudes of 200 mEJPs immediately before and 200 mEJPs immediately after the series of trains at each NMJ. At both control and <italic>OK371&#x003E;mnb</italic> NMJs, the cumulative distribution of mEJP amplitudes before and after a series of trains was similar; although they were not identical, the observed slight increase in the number of larger mEJPs cannot explain the decline in EJP amplitude (<xref ref-type="fig" rid="fig5">Fig. 5C</xref>). These results show that <italic>mnb</italic> overexpression slowed replenishment of the readily releasable pool of vesicles, an effect consistent with the reported slowing of endocytosis of transmitter vesicles by <italic>DYRK1A</italic> overexpression [<xref ref-type="bibr" rid="c32">32</xref>].</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5.</label>
<caption>
<title><italic>mnb</italic> overexpression in motor neurons slowed recovery from frequency-induced depression</title>
<p>(A) <italic>(Left)</italic> Representative pairs of stimulus evoked EJPs at <italic>OK371/&#x002B;</italic> (black) and <italic>OK371&#x003E;mnb</italic> (grey) NMJs. Dashed lines compare the first EJP (EJP<sub>1</sub>) and dotted lines compare the second EJP (EJP<sub>2</sub>). (<italic>Right</italic>) Plots of paired-pulse ratio (EJP<sub>2</sub>/EJP<sub>1</sub>, mean &#x00B1; SEM, <italic>n</italic> &#x003D; 8 for each genotype) against inter-pulse interval reveal no difference in synaptic depression (<italic>F</italic> (9, 126) &#x003D; 0.1343; <italic>n</italic> &#x003D; 8; <italic>P</italic> &#x003D; 0.9987, repeated measures two-way ANOVA). (B) High-frequency stimulation protocol. 10 EJPs were evoked at 0.1 Hz to establish a mean baseline amplitude followed by 8 trains of 10 EJPs at 10 Hz, at one minute intervals. <italic>(Left)</italic> Representative traces of train 1 (<italic>upper</italic>) and train 8 (<italic>lower</italic>) recorded from <italic>OK371/&#x002B;</italic> and <italic>OK371&#x003E;mnb</italic> NMJs. Dashed lines compare EJP<sub>1</sub> in each train. <italic>(Right)</italic> Plots of EJP amplitude during trains 1 and 8, expressed as a fraction of baseline amplitude (mean &#x00B1; SEM, <italic>n</italic> &#x003D; 8 for each genotype). During the first train, the decline in EJP amplitude was unaffected by genotype (<italic>F</italic> (1, 14) &#x003D; 0.22, <italic>P</italic> &#x003D; 0.6486, repeated measures two-way ANOVA). In the eighth train, EJPs were smaller at <italic>OK371&#x003E;mnb</italic> NMJs (<italic>F</italic> (1,14) &#x003D; 4.98, <italic>P</italic> &#x003D; 0.0426) but the rate of decline during the 8<sup>th</sup> train was not different (<italic>F</italic> (9, 126) &#x003D; 0.99, <italic>P</italic> &#x003D; 0.4540, repeated measures two-way ANOVA). (C) Cumulative frequency distributions of mEJP amplitudes (<italic>n</italic> &#x003D; 1600 from 8 NMJ recordings) from immediately before (solid line) and immediately after (dashed line) the trains, for <italic>OK371/&#x002B;</italic> (<italic>left</italic>) and <italic>OK371&#x003E;mnb</italic> (<italic>right</italic>) NMJs; after the trains, a minority of mEJPs were larger and occurred less frequently in both <italic>OK371/&#x002B;</italic> (&#x002A;<italic>P</italic> &#x003D; 0.0117) and <italic>OK371&#x003E;mnb</italic> (&#x002A;<italic>P</italic> &#x003D; 0.018) NMJs (log-rank (Mantel-Cox) test).</p>
</caption>
<graphic xlink:href="370924_fig5.tif"/>
</fig>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>This study demonstrated that neuronal overexpression of <italic>mnb</italic>, the <italic>Drosophila</italic> ortholog of DYRK1A, is sufficient to induce motor impairment, accelerate age-related decline in motor performance, shorten lifespan and cause age-dependent neurodegeneration. This study also found that neuronal <italic>mnb</italic> overexpression at a glutamatergic synapse alters presynaptic structure, modifies basal synaptic transmission and delays recovery from short-term synaptic depression.</p>
<p>People with DS have impaired motor skills which are evident from childhood and are caused by abnormal development of the nervous system [<xref ref-type="bibr" rid="c3">3</xref>, <xref ref-type="bibr" rid="c4">4</xref>]. Later, in middle age, they undergo faster age-dependent motor decline, which is an early marker of future dementia, comorbidities and mortality, and is likely caused by histopathological changes in the brain [<xref ref-type="bibr" rid="c7">7</xref>, <xref ref-type="bibr" rid="c8">8</xref>]. The life expectancy of people with DS is about 28 years shorter than the general population [<xref ref-type="bibr" rid="c9">9</xref>]. By taking advantage of the relatively short life cycle of <italic>Drosophila</italic> and driving overexpression of <italic>mnb</italic> in neurons, we have demonstrated a potential role for neuronal DYRK1A overexpression in the accelerated age-dependent decline of motor function and shortening of life expectancy in DS. The genetic basis of these aspects of DS is more difficult and costly to explore in mouse models of DS, due to the longer time required to study aged mice. Our finding that <italic>mnb</italic> overexpression causes age-related neurodegeneration confirms previous studies inferring a link between <italic>DYRK1A</italic> overexpression and degeneration and loss of neurons [<xref ref-type="bibr" rid="c10">10</xref>, <xref ref-type="bibr" rid="c15">15</xref>, <xref ref-type="bibr" rid="c25">25</xref>, <xref ref-type="bibr" rid="c42">42</xref>], which is associated with faster age-related decline in motor and cognitive function in DS and AD-DS. Our results also reinforce the conclusion from earlier studies with adult mice overexpressing <italic>DYRK1A or Dyrk1a</italic>, alone or as part of a chromosomal segment, that triplication of <italic>DYRK1A</italic> is likely to contribute to motor deficits in DS [<xref ref-type="bibr" rid="c13">13</xref>-<xref ref-type="bibr" rid="c19">19</xref>].</p>
<p>In addition to the smaller brain size and fewer brain neurons in DS and mouse models of DS, there are alterations in the structure of brain synapses that are predicted to modify synaptic function [<xref ref-type="bibr" rid="c4">4</xref>, <xref ref-type="bibr" rid="c28">28</xref>, <xref ref-type="bibr" rid="c50">50</xref>]. A previous study showed that DYRK1A overexpression in mice changes postsynaptic morphology in the cortex and in cultured cortical neurons by reducing the number and length of dendrites and by reducing the number of dendritic spines but elongating their shape [<xref ref-type="bibr" rid="c51">51</xref>]. It also decreased the number of synapses formed. Our study shows that <italic>mnb</italic> overexpression changes presynaptic structure and that this happens in a neuron-specific manner; <italic>mnb</italic> overexpression in the two glutamatergic motoneurons innervating the larval NMJ increased the number of 1b boutons without changing the number of 1s boutons. These data are consistent with a previous study which demonstrated that reduced levels of <italic>mnb</italic> caused a decrease, and increased levels of the <italic>mnb-F</italic> transcript an increase, in the number of boutons at the NMJ [<xref ref-type="bibr" rid="c37">37</xref>], but did not differentiate between 1b and 1s boutons.</p>
<p>The cognitive and motor deficits in DS arise from aberrant information processing in the brain that is likely due, in part, to changes in synaptic transmission or synaptic plasticity. Individuals with DS have impaired synaptic plasticity in the motor cortex [<xref ref-type="bibr" rid="c27">27</xref>]. Our finding that <italic>mnb</italic> overexpression slows replenishment of the readily releasable pool of vesicles, and also modifies basal synaptic transmission, confirms a previous suggestion that DYRK1A overexpression contributes to synaptic dysfunction and cognitive deficits associated with DS, made on the basis of the observed slowing of endocytosis of transmitter vesicles in cultured mouse hippocampal neurons overexpressing human <italic>DYRK1A</italic> [<xref ref-type="bibr" rid="c32">32</xref>]. The effects of <italic>DYRK1A</italic> on synaptic function may be splice variant specific as we found that overexpression of the <italic>mnb-H</italic> transcript caused a decrease in mEJP and EJP amplitude, whereas overexpression of <italic>mnb-F</italic> in a previous study caused an increase in mEJP amplitude and no change in EJP amplitude at the larval NMJ [<xref ref-type="bibr" rid="c37">37</xref>].</p>
<p>The effects of neuronal <italic>mnb</italic> overexpression on larval NMJ function replicate some, but not all, the documented changes in glutamatergic synaptic transmission in the brain of mouse models of DS. These include a decrease in the amplitude of spontaneous excitatory postsynaptic currents (sEPSCs) in neocortical neurons of Ts65Dn mice [<xref ref-type="bibr" rid="c52">52</xref>], compromised glutamate release in response to stimuli trains at hippocampal CA1 synapses of Ts1Cje mice [<xref ref-type="bibr" rid="c53">53</xref>] and a decrease in EPSC amplitude in hippocampal CA3 neurons of Ts65Dn mice [<xref ref-type="bibr" rid="c54">54</xref>]. However, in contrast to the increase in mEJP frequency caused by <italic>mnb</italic> overexpression at the larval NMJ, electrophysiological studies have found a decrease in the frequency of mEPSCs in hippocampal CA3 neurons of Ts65Dn mice, sEPSCs in neocortical neurons of Ts65Dn mice and sEPSCs in neurons derived from trisomy 21 induced pluripotent stem cells, or no change in mEPSC frequency in the prefrontal cortex of TgDyrk1a mice or mossy fibre-CA3 synapses in Tc1 mice [<xref ref-type="bibr" rid="c28">28</xref>].</p>
<p>Our study further elucidates the role of DYRK1A triplication in various DS phenotypes. It supports the future development of pharmacological inhibitors of DYRK1A as treatments for multiple aspects of DS and AD [<xref ref-type="bibr" rid="c10">10</xref>, <xref ref-type="bibr" rid="c12">12</xref>]. Further work is necessary to fully understand interactions between DYRK1A and other triplicated Hsa21 genes in DS, in specific cell types and during defined periods of development and ageing.</p>
</sec>
<sec id="s4">
<title>Materials and Methods</title>
<sec id="s4a">
<title>Animals</title>
<p>Flies were raised with a 12 h:12 h light dark cycle with lights on at ZT 0 (Zeitgeber time) on standard <italic>Drosophila</italic> medium (0.7&#x0025; agar, 1.0&#x0025; soya flour, 8.0&#x0025; polenta/maize, 1.8&#x0025; yeast, 8.0&#x0025; malt extract, 4.0&#x0025; molasses, 0.8&#x0025; propionic acid, 2.3&#x0025; nipagen) at 25&#x00B0;C. Flies were transferred to vials containing fresh medium twice weekly. The <italic>OK371-Gal4</italic> (Bloomington stock center numbers: 26160)<italic>, Elav-Gal4</italic> (87060)<italic>, GMR-Gal4</italic> (9146) flies were obtained from the Bloomington <italic>Drosophila</italic> Stock Centre. <italic>Canton Special white-</italic> (<italic>CSw-</italic>) flies were a gift from Dr S. Waddell (University of Oxford), <italic>UAS-mnb</italic> flies (<italic>minibrain-H</italic>, CG42273) were kindly provided by Dr Kweon Yu (Korea Research Institute of Bioscience and Biotechnology), <italic>EB1-Gal4; UAS</italic>-<italic>mCD8-GFP</italic> flies were donated by Dr F. Hirth (Kings College London).</p>
</sec>
<sec id="s4b">
<title>Behaviour</title>
<p><italic>mnb</italic> expression was driven throughout the nervous system using <italic>Elav-Gal4</italic> [<xref ref-type="bibr" rid="c39">39</xref>] for experiments investigating behaviour of wandering third instar larvae, the number of boutons at the larval NMJ, and synaptic transmission at the larval NMJ. All behavioural experiments took place at 25&#x00B0;C. Larval locomotor experiments were conducted on a 9.5 cm petri dish containing 1.6&#x0025; agarose. A single third instar wandering larva was selected, washed in a drop of distilled H<sub>2</sub>O, transferred to the agarose and allowed 30 s to acclimatise. To analyse free movement, the dish was placed over a 0.5 cm grid and the number of lines the larva crawled across in one minute was counted by eye. The self-righting assay was conducted as described elsewhere [<xref ref-type="bibr" rid="c41">41</xref>, <xref ref-type="bibr" rid="c55">55</xref>]; the larva was gently rolled onto its back on the agarose using a fine moistened paintbrush, held for one second and released, and the time for it to right itself was recorded.</p>
<p>The negative geotaxis assay was performed as described previously [<xref ref-type="bibr" rid="c56">56</xref>]. A cohort of 10 flies was transferred without anaesthesia to an empty 9.5 cm tube with a line drawn 2 cm from the top. After 1 minute acclimatisation, the vial was sharply tapped 3 times to knock the flies to bottom. The number of flies to climb past the line within 10 s was recorded. 15 cohorts of 10 flies were tested for each genotype. Age-dependent changes in climbing were assessed by repeating the negative geotaxis assay at 10, 20 and 30 days post-eclosure [<xref ref-type="bibr" rid="c57">57</xref>]. For the survival assay, 10 cohorts of 10 once-mated females were transferred to a vial of fresh food twice weekly and the number of surviving flies recorded at each transfer.</p>
</sec>
<sec id="s4c">
<title>Antibody staining and visualisation at the NMJ</title>
<p>Wandering third instar larvae were dissected in ice-cold, Ca<sup>2&#x002B;</sup>-free HL3.1-like solution (in mM: 70 NaCl, 5 KCl, 10 NaHCO<sub>3</sub>, 115 sucrose, 5 trehalose, 5 HEPES, 10 MgCl<sub>2</sub>) to produce a larval &#x201C;fillet&#x201D; [<xref ref-type="bibr" rid="c58">58</xref>]. The fillet was fixed for 30 min in 4&#x0025; paraformaldehyde (Sigma Labs), washed three times in 1&#x0025; Triton-X (Sigma Labs) and blocked for one hour in 5&#x0025; normal goat serum (Fitzgerald Industries) and 1&#x0025; Triton-X at room temperature. It was incubated overnight in 1/500 FITC-conjugated anti-horseradish peroxidase (HRP-FITC) (Jackson Immunoresearch Laboratories) and 1/500 mouse anti Discs large (Dlg) primary antibody, then for two hours in 1/500 AlexaFluor 633-conjugated goat anti-mouse secondary antibody at room temperature. Each fillet was washed and mounted on a coverslip in Vectashield (Vector Laboratories). Z-series of NMJs were imaged on a Leica SP5-II confocal laser-scanning microscope using an oil immersion 40 &#x00D7; objective. The number of boutons at the NMJ of muscle 6/7 in segment A2 was counted manually. ImageJ (rsb.info.nih.gov/ij/) was used to manually outline muscle 6 and hence calculate their area.</p>
</sec>
<sec id="s4d">
<title>Neurotoxicity</title>
<p>Overexpression of <italic>mnb</italic> was driven in the eye using the <italic>Glass multimer reporter</italic> (<italic>GMR-Gal4</italic>). Images of the whole head of 1-2 day old flies were taken via a Zeiss AxioCam MRm camera attached to a stereomicroscope (Zeiss SteREO Discovery.V8, up to 8&#x00D7; magnification), and the surface area of the eye was calculated by manually outlining the eye in ImageJ (<ext-link ext-link-type="uri" xlink:href="http://rsb.info.nih.gov/ij/">rsb.info.nih.gov/ij/</ext-link>). Overexpression of <italic>mnb</italic> in GFP-tagged ellipsoid body (EB) ring neurons was achieved by crossing <italic>EB1-Gal4; UAS</italic>-<italic>mCD8-GFP</italic> flies with <italic>UAS</italic>-<italic>mnb</italic> flies. Following published methods [<xref ref-type="bibr" rid="c59">59</xref>], adult brains were dissected, fixed for 30 minutes in 4&#x0025; paraformaldehyde and mounted on a coverslip in Vectashield (Vector Laboratories). Slides were imaged on a Leica SP5-II confocal laser scanning microscope using an oil immersion 40 &#x00D7; objective. A Z-stack of 25 images at 1 &#x03BC;m increments was captured and combined into a 3-D projection using ImageJ (rsb.info.nih.gov/ij/); analysis was performed by scrolling through all 25 images and counting the number of intact cells in one brain hemisphere.</p>
</sec>
<sec id="s4e">
<title>Electrophysiology</title>
<p>Wandering third instar larvae were dissected as for antibody staining. The motor nerves were severed just below the ventral ganglion and the brain was removed. CaCl<sub>2</sub> (1 mM) was added to the bath solution for intracellular recording from muscle 6 of abdominal segments 2-4. Most recordings were made in the presence of thapsigargin (2 &#x03BC;M), which minimises contraction and hence facilitates intracellular recording, without affecting amplitudes of mEJPS or EJPs [<xref ref-type="bibr" rid="c47">47</xref>, <xref ref-type="bibr" rid="c60">60</xref>]. Sharp microelectrodes (thick-walled borosilicate capillaries, pulled on a Sutter Flaming/Brown P-97 micropipette puller) were filled with 3M KCl and had resistances of 20 &#x2013; 30 M&#x03A9;. For recording of stimulus evoked excitatory junction potentials (EJPs), severed nerves were drawn into a thin-walled glass-stimulating pipette and stimulated with square-wave voltage pulses (0.1 ms, 10 V, A-M Systems Model 2100 Isolated Pulse Simulator), 10 times at 0.1 Hz. EJPs and spontaneously-occurring miniature EJPs (mEJPs) were recorded at a controlled room temperature of 22-25&#x00B0;C with a Geneclamp 500 amplifier (Axon Instruments) and were further amplified with a LHBF-48x amplifier (NPI Electronic). The membrane potential was allowed to stabilise for one minute, the initial value was recorded, and then set to &#x2212;70 mV by injecting current with the Geneclamp 500 amplifier. The muscle input resistance was measured by injecting current using the Axon Geneclamp 500, to bring the membrane potential to &#x2212;100, &#x2212;80, &#x2212;60 and &#x2212;40 mV, and subtracting the electrode resistance from the slope of the resulting voltage/current graph. Voltage signals were low-pass filtered at 1.67 kHz (10 kHz 4 pole Bessel on Geneclamp 500, 1.7 kHz 8-pole Bessel on LHBF-48x) and digitised at 25 kHz by a CED-1401 plus A/D interface (Cambridge Electronic Design, UK) using Spike2 software (v. 5.13) (CED, Cambridge, UK). Recordings were discarded if the initial resting membrane potential was more positive than &#x2212;60 mV or varied by more than 10&#x0025; throughout the recording. Synaptic potentials were analysed off line using Strathclyde Electrophysiology Software WinEDR (v3.5.2) and GraphPad Prism (v.6). All synaptic events were verified manually.</p>
<p>Amplitudes and intervals of mEJPs were compared by creating a cumulative distribution for each genotype of 1600 measurements across 8 animals, with each animal contributing 200 values. To analyse the mEJP waveform, a mean mEJP was constructed for each recording from events showing a single clear peak and a smooth decay, so as to prevent distortion of the waveform by closely occurring mEJPs. A single exponential was fitted to the decay of the mean mEJP and the 10-90&#x0025; rise-time was measured. Time zero for the exponential fit was set to the time at the peak of the mEJP. EJPs were analysed by forming a mean of 10 events, measuring the 10-90&#x0025; rise-time of the mean event, and fitting the decay with the sum of three exponentials (time zero was set at the time of the peak). A mean weighted time constant of decay was calculated as A<sub>1</sub>.&#x03C4;<sub>1</sub> &#x002B; A<sub>2</sub>.&#x03C4;<sub>2</sub> &#x002B; A<sub>3</sub>.&#x03C4;<sub>3</sub>, where A<sub>1</sub>, A<sub>2</sub> and A<sub>3</sub> are the fractional amplitudes of the three components, and &#x03C4;<sub>1</sub>, &#x03C4;<sub>2</sub> and &#x03C4;<sub>3</sub> are their time constants.</p>
<p>For paired pulse analysis, two EJPs were evoked, separated with intervals varying in duration between 0.01 and 10 s. The amplitude of the second event was calculated as a fraction of the amplitude of the first. Pairs of stimuli were separated by 30 s. For high&#x2013;frequency stimulation, trains of 10 events evoked at 10 Hz were repeated 8 times at 1 min intervals. The amplitude of each event was expressed as a fraction of a baseline value, defined as the mean amplitude of 10 single EJPs evoked at 0.1 Hz. To compare mEJP amplitude before and after the trains, 200 mEJP amplitudes were measured immediately before the first train, and another 200 immediately after the eighth train. The measured values were pooled from 8 NMJs for each genotype and cumulative amplitude distributions compared.</p>
</sec>
<sec id="s4f">
<title>Statistical analysis</title>
<p>Statistical analysis was conducted in GraphPad Prism (v. 6, La Jolla, CA). Data were tested for normality using the Kolmogorov-Smirnov test; where appropriate means were compared using Student&#x2019;s unpaired <italic>t</italic>-test, or medians were compared using a Mann-Whitney <italic>U</italic> test. EJPs evoked by pairs or trains of stimuli were compared using repeated measures 2-way ANOVA. Cumulative distributions were compared with a Kolmogorov-Smirnov test. Survival curves were compared with a Mantel-Cox test. Data are given as median or mean &#x00B1; SEM. <italic>n</italic> is given per genotype. An &#x03B1; level of <italic>P</italic> &#x003C; 0.05 was considered significant.</p>
</sec>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="c1"><label>1.</label><mixed-citation publication-type="journal"><string-name><surname>Herault</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Delabar</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Fisher</surname> <given-names>EMC</given-names></string-name>, <string-name><surname>Tybulewicz</surname> <given-names>VLJ</given-names></string-name>, <string-name><surname>Yu</surname> <given-names>E</given-names></string-name>, <string-name><surname>Brault</surname> <given-names>V.</given-names></string-name> <article-title>Rodent models in Down syndrome research: impact and future opportunities</article-title>. <source>Dis Model Mech</source>. <year>2017</year>;<volume>10</volume>(<issue>10</issue>):<fpage>1165</fpage>&#x2013;<lpage>86</lpage>. Epub 2017/10/11. doi: <pub-id pub-id-type="doi">10.1242/dmm.029728</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">28993310</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC5665454</pub-id>.</mixed-citation></ref>
<ref id="c2"><label>2.</label><mixed-citation publication-type="journal"><string-name><surname>Lott</surname> <given-names>IT</given-names></string-name>, <string-name><surname>Dierssen</surname> <given-names>M.</given-names></string-name> <article-title>Cognitive deficits and associated neurological complications in individuals with Down&#x2019;s syndrome</article-title>. <source>Lancet Neurol</source>. <year>2010</year>;<volume>9</volume>(<issue>6</issue>):<fpage>623</fpage>&#x2013;<lpage>33</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S1474-4422(10)70112-5</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">20494326</pub-id>.</mixed-citation></ref>
<ref id="c3"><label>3.</label><mixed-citation publication-type="journal"><string-name><surname>Malak</surname> <given-names>R</given-names></string-name>, <string-name><surname>Kostiukow</surname> <given-names>A</given-names></string-name>, <string-name><surname>Krawczyk-Wasielewska</surname> <given-names>A</given-names></string-name>, <string-name><surname>Mojs</surname> <given-names>E</given-names></string-name>, <string-name><surname>Samborski</surname> <given-names>W.</given-names></string-name> <article-title>Delays in Motor Development in Children with Down Syndrome</article-title>. <source>Med Sci Monit</source>. <year>2015</year>;<volume>21</volume>:<fpage>1904</fpage>&#x2013;<lpage>10</lpage>. Epub 2015/07/01. doi: <pub-id pub-id-type="doi">10.12659/MSM.893377</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">26132100</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC4500597</pub-id>.</mixed-citation></ref>
<ref id="c4"><label>4.</label><mixed-citation publication-type="journal"><string-name><surname>Stagni</surname> <given-names>F</given-names></string-name>, <string-name><surname>Giacomini</surname> <given-names>A</given-names></string-name>, <string-name><surname>Emili</surname> <given-names>M</given-names></string-name>, <string-name><surname>Guidi</surname> <given-names>S</given-names></string-name>, <string-name><surname>Bartesaghi</surname> <given-names>R.</given-names></string-name> <article-title>Neurogenesis impairment: An early developmental defect in Down syndrome</article-title>. <source>Free Radic Biol Med</source>. <year>2018</year>;<volume>114</volume>:<fpage>15</fpage>&#x2013;<lpage>32</lpage>. Epub 2017/08/02. doi: <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2017.07.026</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">28756311</pub-id>.</mixed-citation></ref>
<ref id="c5"><label>5.</label><mixed-citation publication-type="journal"><string-name><surname>Wiseman</surname> <given-names>FK</given-names></string-name>, <string-name><surname>Al-Janabi</surname> <given-names>T</given-names></string-name>, <string-name><surname>Hardy</surname> <given-names>J</given-names></string-name>, <string-name><surname>Karmiloff-Smith</surname> <given-names>A</given-names></string-name>, <string-name><surname>Nizetic</surname> <given-names>D</given-names></string-name>, <string-name><surname>Tybulewicz</surname> <given-names>VL</given-names></string-name>, <etal>et al.</etal> <article-title>A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome</article-title>. <source>Nat Rev Neurosci</source>. <year>2015</year>;<volume>16</volume>(<issue>9</issue>):<fpage>564</fpage>&#x2013;<lpage>74</lpage>. Epub 2015/08/05. doi: <pub-id pub-id-type="doi">10.1038/nrn3983</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">26243569</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC4678594</pub-id>.</mixed-citation></ref>
<ref id="c6"><label>6.</label><mixed-citation publication-type="journal"><string-name><surname>Zigman</surname> <given-names>WB.</given-names></string-name> <article-title>Atypical aging in Down syndrome</article-title>. <source>Dev Disabil Res Rev</source>. <year>2013</year>;<volume>18</volume>(<issue>1</issue>):<fpage>51</fpage>&#x2013;<lpage>67</lpage>. doi: <pub-id pub-id-type="doi">10.1002/ddrr.1128</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">23949829</pub-id>.</mixed-citation></ref>
<ref id="c7"><label>7.</label><mixed-citation publication-type="journal"><string-name><surname>Anderson-Mooney</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>Schmitt</surname> <given-names>FA</given-names></string-name>, <string-name><surname>Head</surname> <given-names>E</given-names></string-name>, <string-name><surname>Lott</surname> <given-names>IT</given-names></string-name>, <string-name><surname>Heilman</surname> <given-names>KM.</given-names></string-name> <article-title>Gait dyspraxia as a clinical marker of cognitive decline in Down syndrome: A review of theory and proposed mechanisms</article-title>. <source>Brain Cogn</source>. <year>2016</year>;<volume>104</volume>:<fpage>48</fpage>&#x2013;<lpage>57</lpage>. Epub 2016/02/27. doi: <pub-id pub-id-type="doi">10.1016/j.bandc.2016.02.007</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">26930369</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC4801771</pub-id>.</mixed-citation></ref>
<ref id="c8"><label>8.</label><mixed-citation publication-type="journal"><string-name><surname>Buchman</surname> <given-names>AS</given-names></string-name>, <string-name><surname>Bennett</surname> <given-names>DA.</given-names></string-name> <article-title>Loss of motor function in preclinical Alzheimer&#x2019;s disease</article-title>. <source>Expert Rev Neurother</source>. <year>2011</year>;<volume>11</volume>(<issue>5</issue>):<fpage>665</fpage>&#x2013;<lpage>76</lpage>. doi: <pub-id pub-id-type="doi">10.1586/ern.11.57</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">21539487</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC3121966</pub-id>.</mixed-citation></ref>
<ref id="c9"><label>9.</label><mixed-citation publication-type="journal"><string-name><surname>O&#x2019;Leary</surname> <given-names>L</given-names></string-name>, <string-name><surname>Hughes-McCormack</surname> <given-names>L</given-names></string-name>, <string-name><surname>Dunn</surname> <given-names>K</given-names></string-name>, <string-name><surname>Cooper</surname> <given-names>SA.</given-names></string-name> <article-title>Early death and causes of death of people with Down syndrome: A systematic review</article-title>. <source>J Appl Res Intellect Disabil</source>. <year>2018</year>. Epub 2018/03/25. doi: <pub-id pub-id-type="doi">10.1111/jar.12446</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">29573301</pub-id>.</mixed-citation></ref>
<ref id="c10"><label>10.</label><mixed-citation publication-type="journal"><string-name><surname>Duchon</surname> <given-names>A</given-names></string-name>, <string-name><surname>Herault</surname> <given-names>Y.</given-names></string-name> <article-title>DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome</article-title>. <source>Front Behav Neurosci</source>. <year>2016</year>;<volume>10</volume>:<fpage>104</fpage>. Epub 2016/06/03. doi: <pub-id pub-id-type="doi">10.3389/fnbeh.2016.00104</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">27375444</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC4891327</pub-id>.</mixed-citation></ref>
<ref id="c11"><label>11.</label><mixed-citation publication-type="journal"><string-name><surname>Kay</surname> <given-names>LJ</given-names></string-name>, <string-name><surname>Smulders-Srinivasan</surname> <given-names>TK</given-names></string-name>, <string-name><surname>Soundararajan</surname> <given-names>M.</given-names></string-name> <article-title>Understanding the Multifaceted Role of Human Down Syndrome Kinase DYRK1A</article-title>. <source>Adv Protein Chem Struct Biol</source>. <year>2016</year>;<volume>105</volume>:<fpage>127</fpage>&#x2013;<lpage>71</lpage>. Epub 2016/08/29. doi: <pub-id pub-id-type="doi">10.1016/bs.apcsb.2016.07.001</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">27567487</pub-id>.</mixed-citation></ref>
<ref id="c12"><label>12.</label><mixed-citation publication-type="journal"><string-name><surname>Stringer</surname> <given-names>M</given-names></string-name>, <string-name><surname>Goodlett</surname> <given-names>CR</given-names></string-name>, <string-name><surname>Roper</surname> <given-names>RJ.</given-names></string-name> <article-title>Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits</article-title>. <source>Mol Genet Genomic Med</source>. <year>2017</year>;<volume>5</volume>(<issue>5</issue>):<fpage>451</fpage>&#x2013;<lpage>65</lpage>. Epub 2017/09/26. doi: <pub-id pub-id-type="doi">10.1002/mgg3.334</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">28944229</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC5606891</pub-id>.</mixed-citation></ref>
<ref id="c13"><label>13.</label><mixed-citation publication-type="journal"><string-name><surname>Garcia-Cerro</surname> <given-names>S</given-names></string-name>, <string-name><surname>Vidal</surname> <given-names>V</given-names></string-name>, <string-name><surname>Lantigua</surname> <given-names>S</given-names></string-name>, <string-name><surname>Berciano</surname> <given-names>MT</given-names></string-name>, <string-name><surname>Lafarga</surname> <given-names>M</given-names></string-name>, <string-name><surname>Ramos-Cabrer</surname> <given-names>P</given-names></string-name>, <etal>et al.</etal> <article-title>Cerebellar alterations in a model of Down syndrome: The role of the Dyrk1A gene</article-title>. <source>Neurobiol Dis</source>. <year>2018</year>;<volume>110</volume>:<fpage>206</fpage>&#x2013;<lpage>17</lpage>. Epub 2017/12/10. doi: <pub-id pub-id-type="doi">10.1016/j.nbd.2017.12.002</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">29221819</pub-id>.</mixed-citation></ref>
<ref id="c14"><label>14.</label><mixed-citation publication-type="journal"><string-name><surname>Altafaj</surname> <given-names>X</given-names></string-name>, <string-name><surname>Dierssen</surname> <given-names>M</given-names></string-name>, <string-name><surname>Baamonde</surname> <given-names>C</given-names></string-name>, <string-name><surname>Mart&#x00ED;</surname> <given-names>E</given-names></string-name>, <string-name><surname>Visa</surname> <given-names>J</given-names></string-name>, <string-name><surname>Guimer&#x00E0;</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal> <article-title>Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down&#x2019;s syndrome</article-title>. <source>Hum Mol Genet</source>. <year>2001</year>;<volume>10</volume>(<issue>18</issue>):<fpage>1915</fpage>&#x2013;<lpage>23</lpage>. PubMed PMID: <pub-id pub-id-type="pmid">11555628</pub-id>.</mixed-citation></ref>
<ref id="c15"><label>15.</label><mixed-citation publication-type="journal"><string-name><surname>Watson-Scales</surname> <given-names>S</given-names></string-name>, <string-name><surname>Kalmar</surname> <given-names>B</given-names></string-name>, <string-name><surname>Lana-Elola</surname> <given-names>E</given-names></string-name>, <string-name><surname>Gibbins</surname> <given-names>D</given-names></string-name>, <string-name><surname>La Russa</surname> <given-names>F</given-names></string-name>, <string-name><surname>Wiseman</surname> <given-names>F</given-names></string-name>, <etal>et al.</etal> <article-title>Analysis of motor dysfunction in Down Syndrome reveals motor neuron degeneration</article-title>. <source>PLoS Genet</source>. <year>2018</year>;<volume>14</volume>(<issue>5</issue>):<fpage>e1007383</fpage>. Epub 2018/05/11. doi: <pub-id pub-id-type="doi">10.1371/journal.pgen.1007383</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">29746474</pub-id>.</mixed-citation></ref>
<ref id="c16"><label>16.</label><mixed-citation publication-type="journal"><string-name><surname>Mart&#x00ED;nez de Lagr&#x00E1;n</surname> <given-names>M</given-names></string-name>, <string-name><surname>Altafaj</surname> <given-names>X</given-names></string-name>, <string-name><surname>Gallego</surname> <given-names>X</given-names></string-name>, <string-name><surname>Mart&#x00ED;</surname> <given-names>E</given-names></string-name>, <string-name><surname>Estivill</surname> <given-names>X</given-names></string-name>, <string-name><surname>Sah&#x00FA;n</surname> <given-names>I</given-names></string-name>, <etal>et al.</etal> <article-title>Motor phenotypic alterations in TgDyrk1a transgenic mice implicate DYRK1A in Down syndrome motor dysfunction</article-title>. <source>Neurobiol Dis</source>. <year>2004</year>;<volume>15</volume>(<issue>1</issue>):<fpage>132</fpage>&#x2013;<lpage>42</lpage>. PubMed PMID: <pub-id pub-id-type="pmid">14751778</pub-id>.</mixed-citation></ref>
<ref id="c17"><label>17.</label><mixed-citation publication-type="journal"><string-name><surname>Souchet</surname> <given-names>B</given-names></string-name>, <string-name><surname>Guedj</surname> <given-names>F</given-names></string-name>, <string-name><surname>Sah&#x00FA;n</surname> <given-names>I</given-names></string-name>, <string-name><surname>Duchon</surname> <given-names>A</given-names></string-name>, <string-name><surname>Daubigney</surname> <given-names>F</given-names></string-name>, <string-name><surname>Badel</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal> <article-title>Excitation/inhibition balance and learning are modified by Dyrk1a gene dosage</article-title>. <source>Neurobiol Dis</source>. <year>2014</year>;<volume>69</volume>:<fpage>65</fpage>&#x2013;<lpage>75</lpage>. Epub 2014/05/04. doi: <pub-id pub-id-type="doi">10.1016/j.nbd.2014.04.016</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">24801365</pub-id>.</mixed-citation></ref>
<ref id="c18"><label>18.</label><mixed-citation publication-type="journal"><string-name><surname>Arque</surname> <given-names>G</given-names></string-name>, <string-name><surname>Casanovas</surname> <given-names>A</given-names></string-name>, <string-name><surname>Dierssen</surname> <given-names>M.</given-names></string-name> <article-title>Dyrk1A is dynamically expressed on subsets of motor neurons and in the neuromuscular junction: possible role in Down syndrome</article-title>. <source>PLoS One</source>. <year>2013</year>;<volume>8</volume>(<issue>1</issue>):<fpage>e54285</fpage>. Epub 2013/01/16. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0054285</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">23342120</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC3546979</pub-id>.</mixed-citation></ref>
<ref id="c19"><label>19.</label><mixed-citation publication-type="journal"><string-name><surname>Ortiz-Abalia</surname> <given-names>J</given-names></string-name>, <string-name><surname>Sah&#x00FA;n</surname> <given-names>I</given-names></string-name>, <string-name><surname>Altafaj</surname> <given-names>X</given-names></string-name>, <string-name><surname>Andreu</surname> <given-names>N</given-names></string-name>, <string-name><surname>Estivill</surname> <given-names>X</given-names></string-name>, <string-name><surname>Dierssen</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> <article-title>Targeting Dyrk1A with AAVshRNA attenuates motor alterations in TgDyrk1A, a mouse model of Down syndrome</article-title>. <source>Am J Hum Genet</source>. <year>2008</year>;<volume>83</volume>(<issue>4</issue>):<fpage>479</fpage>&#x2013;<lpage>88</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ajhg.2008.09.010</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">18940310</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC2561933</pub-id>.</mixed-citation></ref>
<ref id="c20"><label>20.</label><mixed-citation publication-type="journal"><string-name><surname>Ahn</surname> <given-names>KJ</given-names></string-name>, <string-name><surname>Jeong</surname> <given-names>HK</given-names></string-name>, <string-name><surname>Choi</surname> <given-names>HS</given-names></string-name>, <string-name><surname>Ryoo</surname> <given-names>SR</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>YJ</given-names></string-name>, <string-name><surname>Goo</surname> <given-names>JS</given-names></string-name>, <etal>et al.</etal> <article-title>DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects</article-title>. <source>Neurobiol Dis</source>. <year>2006</year>;<volume>22</volume>(<issue>3</issue>):<fpage>463</fpage>&#x2013;<lpage>72</lpage>. Epub 2006/02/04. doi: <pub-id pub-id-type="doi">10.1016/j.nbd.2005.12.006</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">16455265</pub-id>.</mixed-citation></ref>
<ref id="c21"><label>21.</label><mixed-citation publication-type="journal"><string-name><surname>Altafaj</surname> <given-names>X</given-names></string-name>, <string-name><surname>Martin</surname> <given-names>ED</given-names></string-name>, <string-name><surname>Ortiz-Abalia</surname> <given-names>J</given-names></string-name>, <string-name><surname>Valderrama</surname> <given-names>A</given-names></string-name>, <string-name><surname>Lao-Peregrin</surname> <given-names>C</given-names></string-name>, <string-name><surname>Dierssen</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> <article-title>Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome</article-title>. <source>Neurobiol Dis</source>. <year>2013</year>;<volume>52</volume>:<fpage>117</fpage>&#x2013;<lpage>27</lpage>. Epub 2012/12/12. doi: <pub-id pub-id-type="doi">10.1016/j.nbd.2012.11.017</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">23220201</pub-id>.</mixed-citation></ref>
<ref id="c22"><label>22.</label><mixed-citation publication-type="journal"><string-name><surname>Garc&#x00ED;a-Cerro</surname> <given-names>S</given-names></string-name>, <string-name><surname>Mart&#x00ED;nez</surname> <given-names>P</given-names></string-name>, <string-name><surname>Vidal</surname> <given-names>V</given-names></string-name>, <string-name><surname>Corrales</surname> <given-names>A</given-names></string-name>, <string-name><surname>Fl&#x00F3;rez</surname> <given-names>J</given-names></string-name>, <string-name><surname>Vidal</surname> <given-names>R</given-names></string-name>, <etal>et al.</etal> <article-title>Overexpression of Dyrk1A is implicated in several cognitive, electrophysiological and neuromorphological alterations found in a mouse model of Down syndrome</article-title>. <source>PLoS One</source>. <year>2014</year>;<volume>9</volume>(<issue>9</issue>):<fpage>e106572</fpage>. Epub 2014/09/04. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0106572</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">25188425</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC4154723</pub-id>.</mixed-citation></ref>
<ref id="c23"><label>23.</label><mixed-citation publication-type="journal"><string-name><surname>Creau</surname> <given-names>N</given-names></string-name>, <string-name><surname>Cabet</surname> <given-names>E</given-names></string-name>, <string-name><surname>Daubigney</surname> <given-names>F</given-names></string-name>, <string-name><surname>Souchet</surname> <given-names>B</given-names></string-name>, <string-name><surname>Bennai</surname> <given-names>S</given-names></string-name>, <string-name><surname>Delabar</surname> <given-names>J.</given-names></string-name> <article-title>Specific age-related molecular alterations in the cerebellum of Down syndrome mouse models</article-title>. <source>Brain Res</source>. <year>2016</year>;<volume>1646</volume>:<fpage>342</fpage>&#x2013;<lpage>53</lpage>. Epub 2016/06/15. doi: <pub-id pub-id-type="doi">10.1016/j.brainres.2016.06.003</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">27297494</pub-id>.</mixed-citation></ref>
<ref id="c24"><label>24.</label><mixed-citation publication-type="journal"><string-name><surname>Ahmed</surname> <given-names>MM</given-names></string-name>, <string-name><surname>Block</surname> <given-names>A</given-names></string-name>, <string-name><surname>Tong</surname> <given-names>S</given-names></string-name>, <string-name><surname>Davisson</surname> <given-names>MT</given-names></string-name>, <string-name><surname>Gardiner</surname> <given-names>KJ.</given-names></string-name> <article-title>Age exacerbates abnormal protein expression in a mouse model of Down syndrome</article-title>. <source>Neurobiol Aging</source>. <year>2017</year>;<volume>57</volume>:<fpage>120</fpage>&#x2013;<lpage>32</lpage>. Epub 2017/06/24. doi: <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2017.05.002</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">28641136</pub-id>.</mixed-citation></ref>
<ref id="c25"><label>25.</label><mixed-citation publication-type="journal"><string-name><surname>Garcia-Cerro</surname> <given-names>S</given-names></string-name>, <string-name><surname>Rueda</surname> <given-names>N</given-names></string-name>, <string-name><surname>Vidal</surname> <given-names>V</given-names></string-name>, <string-name><surname>Lantigua</surname> <given-names>S</given-names></string-name>, <string-name><surname>Martinez-Cue</surname> <given-names>C.</given-names></string-name> <article-title>Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer&#x2019;s disease phenotypes</article-title>. <source>Neurobiol Dis</source>. <year>2017</year>;<volume>106</volume>:<fpage>76</fpage>&#x2013;<lpage>88</lpage>. Epub 2017/06/26. doi: <pub-id pub-id-type="doi">10.1016/j.nbd.2017.06.010</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">28647555</pub-id>.</mixed-citation></ref>
<ref id="c26"><label>26.</label><mixed-citation publication-type="journal"><string-name><surname>Park</surname> <given-names>J</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>EJ</given-names></string-name>, <string-name><surname>Yoon</surname> <given-names>JH</given-names></string-name>, <string-name><surname>Chung</surname> <given-names>KC.</given-names></string-name> <article-title>Dyrk1A overexpression in immortalized hippocampal cells produces the neuropathological features of Down syndrome</article-title>. <source>Mol Cell Neurosci</source>. <year>2007</year>;<volume>36</volume>(<issue>2</issue>):<fpage>270</fpage>&#x2013;<lpage>9</lpage>. Epub 2007/08/28. doi: <pub-id pub-id-type="doi">10.1016/j.mcn.2007.07.007</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">17720532</pub-id>.</mixed-citation></ref>
<ref id="c27"><label>27.</label><mixed-citation publication-type="journal"><string-name><surname>Battaglia</surname> <given-names>F</given-names></string-name>, <string-name><surname>Quartarone</surname> <given-names>A</given-names></string-name>, <string-name><surname>Rizzo</surname> <given-names>V</given-names></string-name>, <string-name><surname>Ghilardi</surname> <given-names>MF</given-names></string-name>, <string-name><surname>Di Rocco</surname> <given-names>A</given-names></string-name>, <string-name><surname>Tortorella</surname> <given-names>G</given-names></string-name>, <etal>et al.</etal> <article-title>Early impairment of synaptic plasticity in patients with Down&#x2019;s syndrome</article-title>. <source>Neurobiol Aging</source>. <year>2008</year>;<volume>29</volume>(<issue>8</issue>):<fpage>1272</fpage>&#x2013;<lpage>5</lpage>. Epub 2007/03/30. <pub-id pub-id-type="doi">doi: 10.1016/j.neurobiolaging.2007.02.025</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">17399853</pub-id>.</mixed-citation></ref>
<ref id="c28"><label>28.</label><mixed-citation publication-type="journal"><string-name><surname>Contestabile</surname> <given-names>A</given-names></string-name>, <string-name><surname>Magara</surname> <given-names>S</given-names></string-name>, <string-name><surname>Cancedda</surname> <given-names>L.</given-names></string-name> <article-title>The GABAergic Hypothesis for Cognitive Disabilities in Down Syndrome</article-title>. <source>Front Cell Neurosci</source>. <year>2017</year>;<volume>11</volume>:<issue>54</issue>. Epub 2017/03/07. doi: <pub-id pub-id-type="doi">10.3389/fncel.2017.00054</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">28326014</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC5339239</pub-id>.</mixed-citation></ref>
<ref id="c29"><label>29.</label><mixed-citation publication-type="journal"><string-name><surname>Ruiz-Mejias</surname> <given-names>M</given-names></string-name>, <string-name><surname>Martinez de Lagran</surname> <given-names>M</given-names></string-name>, <string-name><surname>Mattia</surname> <given-names>M</given-names></string-name>, <string-name><surname>Castano-Prat</surname> <given-names>P</given-names></string-name>, <string-name><surname>Perez-Mendez</surname> <given-names>L</given-names></string-name>, <string-name><surname>Ciria-Suarez</surname> <given-names>L</given-names></string-name>, <etal>et al.</etal> <article-title>Overexpression of Dyrk1A, a Down Syndrome Candidate, Decreases Excitability and Impairs Gamma Oscillations in the Prefrontal Cortex</article-title>. <source>J Neurosci</source>. <year>2016</year>;<volume>36</volume>(<issue>13</issue>):<fpage>3648</fpage>&#x2013;<lpage>59</lpage>. doi: <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2517-15.2016</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">27030752</pub-id>.</mixed-citation></ref>
<ref id="c30"><label>30.</label><mixed-citation publication-type="journal"><string-name><surname>Thomazeau</surname> <given-names>A</given-names></string-name>, <string-name><surname>Lassalle</surname> <given-names>O</given-names></string-name>, <string-name><surname>Iafrati</surname> <given-names>J</given-names></string-name>, <string-name><surname>Souchet</surname> <given-names>B</given-names></string-name>, <string-name><surname>Guedj</surname> <given-names>F</given-names></string-name>, <string-name><surname>Janel</surname> <given-names>N</given-names></string-name>, <etal>et al.</etal> <article-title>Prefrontal deficits in a murine model overexpressing the down syndrome candidate gene dyrk1a</article-title>. <source>J Neurosci</source>. <year>2014</year>;<volume>34</volume>(<issue>4</issue>):<fpage>1138</fpage>&#x2013;<lpage>47</lpage>. Epub 2014/01/24. doi: <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2852-13.2014</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">24453307</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC3953590</pub-id>.</mixed-citation></ref>
<ref id="c31"><label>31.</label><mixed-citation publication-type="journal"><string-name><surname>Murakami</surname> <given-names>N</given-names></string-name>, <string-name><surname>Bolton</surname> <given-names>DC</given-names></string-name>, <string-name><surname>Kida</surname> <given-names>E</given-names></string-name>, <string-name><surname>Xie</surname> <given-names>W</given-names></string-name>, <string-name><surname>Hwang</surname> <given-names>YW.</given-names></string-name> <article-title>Phosphorylation by Dyrk1A of clathrin coated vesicle-associated proteins: identification of the substrate proteins and the effects of phosphorylation</article-title>. <source>PLoS One</source>. <year>2012</year>;<volume>7</volume>(<issue>4</issue>):<fpage>e34845</fpage>. Epub 2012/04/13. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0034845</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">22514676</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC3325943</pub-id>.</mixed-citation></ref>
<ref id="c32"><label>32.</label><mixed-citation publication-type="journal"><string-name><surname>Kim</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Park</surname> <given-names>J</given-names></string-name>, <string-name><surname>Song</surname> <given-names>WJ</given-names></string-name>, <string-name><surname>Chang</surname> <given-names>S.</given-names></string-name> <article-title>Overexpression of Dyrk1A causes the defects in synaptic vesicle endocytosis</article-title>. <source>Neurosignals</source>. <year>2010</year>;<volume>18</volume>(<issue>3</issue>):<fpage>164</fpage>&#x2013;<lpage>72</lpage>. Epub 2010/12/03. doi: <pub-id pub-id-type="doi">10.1159/000321994</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">21135538</pub-id>.</mixed-citation></ref>
<ref id="c33"><label>33.</label><mixed-citation publication-type="journal"><string-name><surname>Bykhovskaia</surname> <given-names>M</given-names></string-name>, <string-name><surname>Vasin</surname> <given-names>A.</given-names></string-name> <article-title>Electrophysiological analysis of synaptic transmission in Drosophila</article-title>. <source>Wiley Interdiscip Rev Dev Biol</source>. <year>2017</year>. Epub 2017/05/24. doi: <pub-id pub-id-type="doi">10.1002/wdev.277</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">28544556</pub-id>.</mixed-citation></ref>
<ref id="c34"><label>34.</label><mixed-citation publication-type="journal"><string-name><surname>McGurk</surname> <given-names>L</given-names></string-name>, <string-name><surname>Berson</surname> <given-names>A</given-names></string-name>, <string-name><surname>Bonini</surname> <given-names>NM.</given-names></string-name> <article-title>Drosophila as an In Vivo Model for Human Neurodegenerative Disease</article-title>. <source>Genetics</source>. <year>2015</year>;<volume>201</volume>(<issue>2</issue>):<fpage>377</fpage>&#x2013;<lpage>402</lpage>. doi: <pub-id pub-id-type="doi">10.1534/genetics.115.179457</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">26447127</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC4596656</pub-id>.</mixed-citation></ref>
<ref id="c35"><label>35.</label><mixed-citation publication-type="journal"><string-name><surname>Lenz</surname> <given-names>S</given-names></string-name>, <string-name><surname>Karsten</surname> <given-names>P</given-names></string-name>, <string-name><surname>Schulz</surname> <given-names>JB</given-names></string-name>, <string-name><surname>Voigt</surname> <given-names>A.</given-names></string-name> <article-title>Drosophila as a screening tool to study human neurodegenerative diseases</article-title>. <source>J Neurochem</source>. <year>2013</year>;<volume>127</volume>(<issue>4</issue>):<fpage>453</fpage>&#x2013;<lpage>60</lpage>. Epub 2013/10/21. doi: <pub-id pub-id-type="doi">10.1111/jnc.12446</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">24028575</pub-id>.</mixed-citation></ref>
<ref id="c36"><label>36.</label><mixed-citation publication-type="journal"><string-name><surname>Jones</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Grotewiel</surname> <given-names>M.</given-names></string-name> <article-title>Drosophila as a model for age-related impairment in locomotor and other behaviors</article-title>. <source>Exp Gerontol</source>. <year>2011</year>;<volume>46</volume>(<issue>5</issue>):<fpage>320</fpage>&#x2013;<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.exger.2010.08.012</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">20800672</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC3021004</pub-id>.</mixed-citation></ref>
<ref id="c37"><label>37.</label><mixed-citation publication-type="journal"><string-name><surname>Chen</surname> <given-names>CK</given-names></string-name>, <string-name><surname>Bregere</surname> <given-names>C</given-names></string-name>, <string-name><surname>Paluch</surname> <given-names>J</given-names></string-name>, <string-name><surname>Lu</surname> <given-names>JF</given-names></string-name>, <string-name><surname>Dickman</surname> <given-names>DK</given-names></string-name>, <string-name><surname>Chang</surname> <given-names>KT.</given-names></string-name> <article-title>Activity-dependent facilitation of Synaptojanin and synaptic vesicle recycling by the Minibrain kinase</article-title>. <source>Nat Commun</source>. <year>2014</year>;<volume>5</volume>:<fpage>4246</fpage>. doi: <pub-id pub-id-type="doi">10.1038/ncomms5246</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">24977345</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC4183159</pub-id>.</mixed-citation></ref>
<ref id="c38"><label>38.</label><mixed-citation publication-type="journal"><string-name><surname>Hong</surname> <given-names>SH</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>KS</given-names></string-name>, <string-name><surname>Kwak</surname> <given-names>SJ</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>AK</given-names></string-name>, <string-name><surname>Bai</surname> <given-names>H</given-names></string-name>, <string-name><surname>Jung</surname> <given-names>MS</given-names></string-name>, <etal>et al.</etal> <article-title>Minibrain/Dyrk1a regulates food intake through the Sir2-FOXO-sNPF/NPY pathway in Drosophila and mammals</article-title>. <source>PLoS Genet</source>. <year>2012</year>;<volume>8</volume>(<issue>8</issue>):<fpage>e1002857</fpage>. Epub 2012/08/02. doi: <pub-id pub-id-type="doi">10.1371/journal.pgen.1002857</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">22876196</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC3410862</pub-id>.</mixed-citation></ref>
<ref id="c39"><label>39.</label><mixed-citation publication-type="journal"><string-name><surname>Robinow</surname> <given-names>S</given-names></string-name>, <string-name><surname>White</surname> <given-names>K.</given-names></string-name> <article-title>Characterization and spatial distribution of the ELAV protein during Drosophila melanogaster development</article-title>. <source>J Neurobiol</source>. <year>1991</year>;<volume>22</volume>(<issue>5</issue>):<fpage>443</fpage>&#x2013;<lpage>61</lpage>. doi: <pub-id pub-id-type="doi">10.1002/neu.480220503</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">1716300</pub-id>.</mixed-citation></ref>
<ref id="c40"><label>40.</label><mixed-citation publication-type="journal"><string-name><surname>Kohsaka</surname> <given-names>H</given-names></string-name>, <string-name><surname>Guertin</surname> <given-names>PA</given-names></string-name>, <string-name><surname>Nose</surname> <given-names>A.</given-names></string-name> <article-title>Neural Circuits Underlying Fly Larval Locomotion</article-title>. <source>Curr Pharm Des</source>. <year>2017</year>;<volume>23</volume>(<issue>12</issue>):<fpage>1722</fpage>&#x2013;<lpage>33</lpage>. Epub 2016/12/09. doi: <pub-id pub-id-type="doi">10.2174/1381612822666161208120835</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">27928962</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC5470056</pub-id>.</mixed-citation></ref>
<ref id="c41"><label>41.</label><mixed-citation publication-type="journal"><string-name><surname>Picao-Osorio</surname> <given-names>J</given-names></string-name>, <string-name><surname>Johnston</surname> <given-names>J</given-names></string-name>, <string-name><surname>Landgraf</surname> <given-names>M</given-names></string-name>, <string-name><surname>Berni</surname> <given-names>J</given-names></string-name>, <string-name><surname>Alonso</surname> <given-names>CR.</given-names></string-name> <article-title>MicroRNA-encoded behavior in Drosophila</article-title>. <source>Science</source>. <year>2015</year>;<volume>350</volume>(<issue>6262</issue>):<fpage>815</fpage>&#x2013;<lpage>20</lpage>. doi: <pub-id pub-id-type="doi">10.1126/science.aad0217</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">26494171</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC4902127</pub-id>.</mixed-citation></ref>
<ref id="c42"><label>42.</label><mixed-citation publication-type="journal"><string-name><surname>Wegiel</surname> <given-names>J</given-names></string-name>, <string-name><surname>Dowjat</surname> <given-names>K</given-names></string-name>, <string-name><surname>Kaczmarski</surname> <given-names>W</given-names></string-name>, <string-name><surname>Kuchna</surname> <given-names>I</given-names></string-name>, <string-name><surname>Nowicki</surname> <given-names>K</given-names></string-name>, <string-name><surname>Frackowiak</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal> <article-title>The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome</article-title>. <source>Acta Neuropathol</source>. <year>2008</year>;<volume>116</volume>(<issue>4</issue>):<fpage>391</fpage>&#x2013;<lpage>407</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00401-008-0419-6</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">18696092</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC2656568</pub-id>.</mixed-citation></ref>
<ref id="c43"><label>43.</label><mixed-citation publication-type="journal"><string-name><surname>Ellis</surname> <given-names>MC</given-names></string-name>, <string-name><surname>O&#x2019;Neill</surname> <given-names>EM</given-names></string-name>, <string-name><surname>Rubin</surname> <given-names>GM.</given-names></string-name> <article-title>Expression of Drosophila glass protein and evidence for negative regulation of its activity in non-neuronal cells by another DNA-binding protein</article-title>. <source>Development</source>. <year>1993</year>;<volume>119</volume>(<issue>3</issue>):<fpage>855</fpage>&#x2013;<lpage>65</lpage>. PubMed PMID: <pub-id pub-id-type="pmid">8187644</pub-id>.</mixed-citation></ref>
<ref id="c44"><label>44.</label><mixed-citation publication-type="journal"><string-name><surname>Diaper</surname> <given-names>DC</given-names></string-name>, <string-name><surname>Adachi</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Sutcliffe</surname> <given-names>B</given-names></string-name>, <string-name><surname>Humphrey</surname> <given-names>DM</given-names></string-name>, <string-name><surname>Elliott</surname> <given-names>CJ</given-names></string-name>, <string-name><surname>Stepto</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal> <article-title>Loss and gain of Drosophila TDP-43 impair synaptic efficacy and motor control leading to age-related neurodegeneration by loss-of-function phenotypes</article-title>. <source>Hum Mol Genet</source>. <year>2013</year>;<volume>22</volume>(<issue>8</issue>):<fpage>1539</fpage>&#x2013;<lpage>57</lpage>. doi: <pub-id pub-id-type="doi">10.1093/hmg/ddt005</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">23307927</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC3605831</pub-id>.</mixed-citation></ref>
<ref id="c45"><label>45.</label><mixed-citation publication-type="journal"><string-name><surname>Mahr</surname> <given-names>A</given-names></string-name>, <string-name><surname>Aberle</surname> <given-names>H.</given-names></string-name> <article-title>The expression pattern of the Drosophila vesicular glutamate transporter: a marker protein for motoneurons and glutamatergic centers in the brain</article-title>. <source>Gene Expr Patterns</source>. <year>2006</year>;<volume>6</volume>(<issue>3</issue>):<fpage>299</fpage>&#x2013;<lpage>309</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.modgep.2005.07.006</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">16378756</pub-id>.</mixed-citation></ref>
<ref id="c46"><label>46.</label><mixed-citation publication-type="journal"><string-name><surname>Lahey</surname> <given-names>T</given-names></string-name>, <string-name><surname>Gorczyca</surname> <given-names>M</given-names></string-name>, <string-name><surname>Jia</surname> <given-names>XX</given-names></string-name>, <string-name><surname>Budnik</surname> <given-names>V.</given-names></string-name> <article-title>The Drosophila tumor suppressor gene dlg is required for normal synaptic bouton structure</article-title>. <source>Neuron</source>. <year>1994</year>;<volume>13</volume>(<issue>4</issue>):<fpage>823</fpage>&#x2013;<lpage>35</lpage>. PubMed PMID: <pub-id pub-id-type="pmid">7946331</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC4661177</pub-id>.</mixed-citation></ref>
<ref id="c47"><label>47.</label><mixed-citation publication-type="journal"><string-name><surname>Newman</surname> <given-names>ZL</given-names></string-name>, <string-name><surname>Hoagland</surname> <given-names>A</given-names></string-name>, <string-name><surname>Aghi</surname> <given-names>K</given-names></string-name>, <string-name><surname>Worden</surname> <given-names>K</given-names></string-name>, <string-name><surname>Levy</surname> <given-names>SL</given-names></string-name>, <string-name><surname>Son</surname> <given-names>JH</given-names></string-name>, <etal>et al.</etal> <article-title>Input-Specific Plasticity and Homeostasis at the Drosophila Larval Neuromuscular Junction</article-title>. <source>Neuron</source>. <year>2017</year>;<volume>93</volume>(<issue>6</issue>):<fpage>1388</fpage>&#x2013;<lpage>404.e10</lpage>. Epub 2017/03/09. doi: <pub-id pub-id-type="doi">10.1016/j.neuron.2017.02.028</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">28285823</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC5464967</pub-id>.</mixed-citation></ref>
<ref id="c48"><label>48.</label><mixed-citation publication-type="journal"><string-name><surname>Kauwe</surname> <given-names>G</given-names></string-name>, <string-name><surname>Isacoff</surname> <given-names>EY.</given-names></string-name> <article-title>Rapid feedback regulation of synaptic efficacy during high-frequency activity at the Drosophila larval neuromuscular junction</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2013</year>;<volume>110</volume>(<issue>22</issue>):<fpage>9142</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1221314110</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">23674684</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC3670382</pub-id>.</mixed-citation></ref>
<ref id="c49"><label>49.</label><mixed-citation publication-type="journal"><string-name><surname>Regehr</surname> <given-names>WG.</given-names></string-name> <article-title>Short-term presynaptic plasticity</article-title>. <source>Cold Spring Harb Perspect Biol</source>. <year>2012</year>;<volume>4</volume>(<issue>7</issue>):<fpage>a005702</fpage>. Epub 2012/07/04. doi: <pub-id pub-id-type="doi">10.1101/cshperspect.a005702</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">22751149</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC3385958</pub-id>.</mixed-citation></ref>
<ref id="c50"><label>50.</label><mixed-citation publication-type="journal"><string-name><surname>Dierssen</surname> <given-names>M.</given-names></string-name> <article-title>Down syndrome: the brain in trisomic mode</article-title>. <source>Nat Rev Neurosci</source>. <volume>13</volume>. England<year>2012</year>. p. <fpage>844</fpage>&#x2013;<lpage>58</lpage>.</mixed-citation></ref>
<ref id="c51"><label>51.</label><mixed-citation publication-type="journal"><string-name><surname>Martinez de Lagran</surname> <given-names>M</given-names></string-name>, <string-name><surname>Benavides-Piccione</surname> <given-names>R</given-names></string-name>, <string-name><surname>Ballesteros-Ya&#x00F1;ez</surname> <given-names>I</given-names></string-name>, <string-name><surname>Calvo</surname> <given-names>M</given-names></string-name>, <string-name><surname>Morales</surname> <given-names>M</given-names></string-name>, <string-name><surname>Fillat</surname> <given-names>C</given-names></string-name>, <etal>et al.</etal> <article-title>Dyrk1A influences neuronal morphogenesis through regulation of cytoskeletal dynamics in mammalian cortical neurons</article-title>. <source>Cereb Cortex</source>. <year>2012</year>;<volume>22</volume>(<issue>12</issue>):<fpage>2867</fpage>&#x2013;<lpage>77</lpage>. doi: <pub-id pub-id-type="doi">10.1093/cercor/bhr362</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">22215728</pub-id>.</mixed-citation></ref>
<ref id="c52"><label>52.</label><mixed-citation publication-type="journal"><string-name><surname>Cramer</surname> <given-names>NP</given-names></string-name>, <string-name><surname>Xu</surname> <given-names>X</given-names></string-name>, T FH, <string-name><surname>Galdzicki</surname> <given-names>Z.</given-names></string-name> <article-title>Altered intrinsic and network properties of neocortical neurons in the Ts65Dn mouse model of Down syndrome</article-title>. <source>Physiol Rep</source>. <year>2015</year>;<volume>3</volume>(<issue>12</issue>). Epub 2015/12/25. doi: <pub-id pub-id-type="doi">10.14814/phy2.12655</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">26702072</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC4760451</pub-id>.</mixed-citation></ref>
<ref id="c53"><label>53.</label><mixed-citation publication-type="journal"><string-name><surname>Siarey</surname> <given-names>RJ</given-names></string-name>, <string-name><surname>Villar</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>Epstein</surname> <given-names>CJ</given-names></string-name>, <string-name><surname>Galdzicki</surname> <given-names>Z.</given-names></string-name> <article-title>Abnormal synaptic plasticity in the Ts1Cje segmental trisomy 16 mouse model of Down syndrome</article-title>. <source>Neuropharmacology</source>. <year>2005</year>;<volume>49</volume>(<issue>1</issue>):<fpage>122</fpage>&#x2013;<lpage>8</lpage>. Epub 2005/07/05. doi: <pub-id pub-id-type="doi">10.1016/j.neuropharm.2005.02.012</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">15992587</pub-id>.</mixed-citation></ref>
<ref id="c54"><label>54.</label><mixed-citation publication-type="journal"><string-name><surname>Hanson</surname> <given-names>JE</given-names></string-name>, <string-name><surname>Blank</surname> <given-names>M</given-names></string-name>, <string-name><surname>Valenzuela</surname> <given-names>RA</given-names></string-name>, <string-name><surname>Garner</surname> <given-names>CC</given-names></string-name>, <string-name><surname>Madison</surname> <given-names>DV.</given-names></string-name> <article-title>The functional nature of synaptic circuitry is altered in area CA3 of the hippocampus in a mouse model of Down&#x2019;s syndrome</article-title>. <source>J Physiol</source>. <year>2007</year>;<volume>579</volume>(<issue>Pt 1</issue>):<fpage>53</fpage>&#x2013;<lpage>67</lpage>. Epub 2006/12/07. doi: <pub-id pub-id-type="doi">10.1113/jphysiol.2006.114868</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">17158177</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC2075378</pub-id>.</mixed-citation></ref>
<ref id="c55"><label>55.</label><mixed-citation publication-type="journal"><string-name><surname>Lowe</surname> <given-names>SA</given-names></string-name>, <string-name><surname>Hodge</surname> <given-names>JJL</given-names></string-name>, <string-name><surname>Usowicz</surname> <given-names>MM.</given-names></string-name> <article-title>A third copy of the Down syndrome cell adhesion molecule (Dscam) causes synaptic and locomotor dysfunction in Drosophila</article-title>. <source>Neurobiol Dis</source>. <year>2018</year>;<volume>110</volume>:<fpage>93</fpage>&#x2013;<lpage>101</lpage>. Epub 2017/12/03. doi: <pub-id pub-id-type="doi">10.1016/j.nbd.2017.11.013</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">29196216</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC5773243</pub-id>.</mixed-citation></ref>
<ref id="c56"><label>56.</label><mixed-citation publication-type="journal"><string-name><surname>Ali</surname> <given-names>YO</given-names></string-name>, <string-name><surname>Escala</surname> <given-names>W</given-names></string-name>, <string-name><surname>Ruan</surname> <given-names>K</given-names></string-name>, <string-name><surname>Zhai</surname> <given-names>RG.</given-names></string-name> <article-title>Assaying locomotor, learning, and memory deficits in Drosophila models of neurodegeneration</article-title>. <source>J Vis Exp</source>. <year>2011</year>;(<issue>49</issue>). Epub 2011/03/11. doi: <pub-id pub-id-type="doi">10.3791/2504</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">21445036</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC3197301</pub-id>.</mixed-citation></ref>
<ref id="c57"><label>57.</label><mixed-citation publication-type="journal"><string-name><surname>Gargano</surname> <given-names>JW</given-names></string-name>, <string-name><surname>Martin</surname> <given-names>I</given-names></string-name>, <string-name><surname>Bhandari</surname> <given-names>P</given-names></string-name>, <string-name><surname>Grotewiel</surname> <given-names>MS.</given-names></string-name> <article-title>Rapid iterative negative geotaxis (RING): a new method for assessing age-related locomotor decline in Drosophila</article-title>. <source>Exp Gerontol</source>. <year>2005</year>;<volume>40</volume>(<issue>5</issue>):<fpage>386</fpage>&#x2013;<lpage>95</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.exger.2005.02.005</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">15919590</pub-id>.</mixed-citation></ref>
<ref id="c58"><label>58.</label><mixed-citation publication-type="journal"><string-name><surname>Brent</surname> <given-names>JR</given-names></string-name>, <string-name><surname>Werner</surname> <given-names>KM</given-names></string-name>, <string-name><surname>McCabe</surname> <given-names>BD.</given-names></string-name> <article-title>Drosophila larval NMJ dissection</article-title>. <source>J Vis Exp</source>. <year>2009</year>;(<issue>24</issue>). doi: <pub-id pub-id-type="doi">10.3791/1107</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">19229190</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC2762896</pub-id>.</mixed-citation></ref>
<ref id="c59"><label>59.</label><mixed-citation publication-type="journal"><string-name><surname>Williamson</surname> <given-names>WR</given-names></string-name>, <string-name><surname>Hiesinger</surname> <given-names>PR.</given-names></string-name> <article-title>Preparation of developing and adult Drosophila brains and retinae for live imaging</article-title>. <source>J Vis Exp</source>. <year>2010</year>;(<issue>37</issue>). doi: <pub-id pub-id-type="doi">10.3791/1936</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">20231817</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC2926941</pub-id>.</mixed-citation></ref>
<ref id="c60"><label>60.</label><mixed-citation publication-type="journal"><string-name><surname>Guerrero</surname> <given-names>G</given-names></string-name>, <string-name><surname>Reiff</surname> <given-names>DF</given-names></string-name>, <string-name><surname>Agarwal</surname> <given-names>G</given-names></string-name>, <string-name><surname>Ball</surname> <given-names>RW</given-names></string-name>, <string-name><surname>Borst</surname> <given-names>A</given-names></string-name>, <string-name><surname>Goodman</surname> <given-names>CS</given-names></string-name>, <etal>et al.</etal> <article-title>Heterogeneity in synaptic transmission along a Drosophila larval motor axon</article-title>. <source>Nat Neurosci</source>. <year>2005</year>;<volume>8</volume>(<issue>9</issue>):<fpage>1188</fpage>&#x2013;<lpage>96</lpage>. Epub 2005/08/24. doi: <pub-id pub-id-type="doi">10.1038/nn1526</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">16116446</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC1402256</pub-id>.</mixed-citation></ref>
</ref-list>
</back>
</article>